Due to inflation and large costs for subsidized medicines – including Novo Nordisk’s diabetes medicine Ozempic – Region Midtjylland council chairman Anders Kühnau now says the DKK2 billion financial aid given by the government in February is not enough, DR reports. Anders said this meant the region could not continue treating patients on waiting lists without overspending its budget. Minister of Health Sophie Løhde said all regions in Denmark signed an agreement during the healthcare emergency plan announcement that stated the regions would ensure waiting lists at hospitals would reduce by 2024 and return to pre-pandemic times. “So, I am really surprised that they (Region Midtjylland) are now saying they cannot live up to it. The agreement was confirmed in June, and they (regions) were also allowed to access DKK350 million in funds at their own discretion,” she said.
